Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-09

Clinical Trial Update: Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial [NA]

View source ↗

Summary

A prospective interventional trial evaluating finerenone for IgA nephropathy is currently recruiting at Botkin Hospital, with no results reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Finerenone (finerenone)

Snippet

Sponsor: Botkin Hospital | Conditions: IgA Nephropathy (IgAN) | NA | Status: RECRUITING